Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

11.50
+0.76007.08%
Post-market: 11.500.00000.00%16:23 EDT
Volume:1.12M
Turnover:12.48M
Market Cap:604.94M
PE:-7.30
High:11.82
Open:10.86
Low:10.46
Close:10.74
Loading ...

Tyra Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
15 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Medtronic (MDT) and Tyra Bioscience (TYRA)

TIPRANKS
·
19 Feb

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Feb

Buy Rating Reiterated: TYRA-300 Outshines Competitor with Superior Efficacy and Tolerability

TIPRANKS
·
18 Feb

Tyra Biosciences to Present at Upcoming Investor Conferences

PR Newswire
·
12 Feb

Director’s Stock Sale Unveils Major Moves at Tyra Bioscience!

TIPRANKS
·
08 Feb

Tyra Biosciences Insider Ups Holding By 284% During Year

Simply Wall St.
·
30 Jan

Tyra Biosciences Appoints Adele M. Gulfo to Board

TIPRANKS
·
30 Jan

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

THOMSON REUTERS
·
30 Jan

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

PR Newswire
·
30 Jan

Private equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33%

Simply Wall St.
·
27 Jan

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium

PR Newswire
·
22 Jan

Bank of America Securities Remains a Buy on Tyra Bioscience (TYRA)

TIPRANKS
·
16 Jan

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Jan

Positive Outlook for Tyra Bioscience Following FDA Clearance and Promising Clinical Data

TIPRANKS
·
13 Jan